Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs
The Biden administration's proposal to expand coverage for weight-loss drugs like Ozempic and Mounjaro in government healthcare plans could reduce costs and make the drugs available to more patients by 2026.